ArticleJournal of clinical hypertension (Greenwich, Conn.)2024

The prevalence of monotherapy and combination therapy in hypertension in China from 2019 to 2021: A nationwide population-based cross-sectional study.

Xiaoyang Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.